Does LENALIDOMIDE Cause Primary mediastinal large b-cell lymphoma recurrent? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Primary mediastinal large b-cell lymphoma recurrent have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.0% of all adverse event reports for LENALIDOMIDE.
5
Reports of Primary mediastinal large b-cell lymphoma recurrent with LENALIDOMIDE
0.0%
of all LENALIDOMIDE reports
4
Deaths
0
Hospitalizations
How Dangerous Is Primary mediastinal large b-cell lymphoma recurrent From LENALIDOMIDE?
Of the 5 reports, 4 (80.0%) resulted in death.
Is Primary mediastinal large b-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LENALIDOMIDE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does LENALIDOMIDE Cause?
Diarrhoea (27,576)
Fatigue (22,956)
Death (19,213)
Off label use (17,017)
Rash (15,794)
Pneumonia (14,807)
Plasma cell myeloma (14,191)
Neuropathy peripheral (10,215)
White blood cell count decreased (9,996)
Constipation (9,635)
What Other Drugs Cause Primary mediastinal large b-cell lymphoma recurrent?
RITUXIMAB (17)
PREDNISONE (15)
CYCLOPHOSPHAMIDE (13)
VINCRISTINE (13)
ETOPOSIDE (10)
BLEOMYCIN (9)
DOXORUBICIN (8)
AXICABTAGENE CILOLEUCEL (7)
FLUDARABINE (6)
ENDOXAN BAXTER (5)
Which LENALIDOMIDE Alternatives Have Lower Primary mediastinal large b-cell lymphoma recurrent Risk?
LENALIDOMIDE vs LENIOLISIB
LENALIDOMIDE vs LENOGRASTIM
LENALIDOMIDE vs LENVATINIB
LENALIDOMIDE vs LEPONEX
LENALIDOMIDE vs LERCANIDIPINE